Real medicine,
Real oversight.
We won't ship anything we wouldn't take ourselves. Every peptide is compounded by an FDA-registered pharmacy, batch-tested by an independent lab, and prescribed only after a clinician has read your file. Here's exactly what that means.
Patient-specific compounding, prescription-
driven
Meto works exclusively with 503A pharmacies — state-licensed facilities that compound each prescription on receipt of an individual order from a licensed clinician. They operate under USP <795> and <797> standards, are FDA-registered, and are inspected by their state board of pharmacy. This is the same regulatory pathway that fills every other compounded prescription your doctor might write.
- State board of pharmacy registered
- Patient-specific prescriptions only
- FDA-registered facility
- USP <795> / <797> compliance
- Third-party batch testing (identity, potency, endotoxins)
- Cold-chain shipping where required
Where we stand.
Late 2023
FDA Category 2 placement
A handful of peptides (BPC-157, CJC-1295, Ipamorelin and others) are placed in Category 2 of the bulk drug substances list — restricting compounding pharmacies' ability to source and compound them at scale.
Feb 2026
HHS announces reclassification
After industry petitions and a coordinated clinical response, HHS announces reclassification of approximately 14 peptides back to compounding-eligible status. This is what re-opened the field.
Jul 2026
FDA advisory committee meets
The FDA's Pharmacy Compounding Advisory Committee (PCAC) reviews the peptide list with industry input. The expected outcome is formal guidance on which peptides remain compounding-eligible long-term.
Ongoing
Meto operates inside the framework
Every peptide we ship today is sourced from a 503A pharmacy operating in compliance with the current regulatory posture. We monitor and adapt as guidance evolves — and we'll never ship anything outside the framework.
No prescription
without a real read.
Meto's clinicians are board-certified MDs and licensed nurse practitioners. The same clinician signs every refill — no rotating team, no black box, no auto-approvals.
State licensure
Every prescription is written by a clinician licensed in your state.
Board certification
MDs board-certified in their specialty. NPs nationally board-certified plus state licensed.
Lab review
Every protocol approval requires a documented review of your Peptide Readiness Panel.
Continuity
The same clinician follows you through refills, adjustments and outcome reviews.
Cold-chain shipping
From 2–8 °C, door to
door.
Lyophilised peptides are shipped reconstituted-ready in insulated packaging with gel packs rated for the destination's climate. Shipments include a temperature indicator strip — and if a package is delayed or arrives compromised, we re-ship for free.
What you'll get
- Insulated EPP container
- Temperature indicator strip
- Climate-rated gel packs
- Free re-ship on compromise
What partnering provides
Every batch,
independently tested.
Identity
Mass spectrometry confirms the peptide is what the label says it is.
Potency
HPLC quantifies the active concentration — every Meto peptide ships at ≥98% purity.
Contamination
Endotoxin, microbial and heavy-metal screens. Certificates of Analysis available on request.
The lines we won't cross.
Controlled substances
Meto does not prescribe Schedule II–IV substances under any circumstance.
Off-framework peptides
If a peptide isn't compounding-eligible under current FDA guidance, we don't ship it. Period.
WADA-banned for testing athletes
If you compete under WADA, we'll flag relevant peptides at intake. We'll prescribe only with explicit acknowledgement.
Anything a clinician decides isn't right for you
If your labs or history make a protocol unsafe, we'll tell you — and the membership covers the visit either way.
Start with the intake.
Membership activates at checkout.
Intake takes about 8 minutes. If your clinician says a protocol is a fit, your $29 membership kicks in the day you approve the Rx — not before.